HC
Hyung Chun
VCPartner, Foresite Capital
Physician-scientist investing across therapeutic areas
San Francisco, CA2 notable investments
Series ASeries B+
BioHealthcare
Background
Hyung Chun is a Partner at Foresite Capital, promoted in June 2024 after joining in 2021. He is a board-certified cardiologist who maintains an adjunct faculty position at Yale School of Medicine. He received an AB with honors from Harvard College, an MD from Johns Hopkins, and completed cardiovascular fellowship at Stanford. He has published in Nature, Science, and NEJM and is an inventor on multiple patents. He serves as board member at Modal Therapeutics and Indomo.
Investment Thesis
Cross-therapeutic area investments in private and public biotech where clinical and scientific rigor provide durable competitive advantage.
Investment Focus
Stages
Series ASeries B+
Sectors
BioHealthcare
Based in: San Francisco, CA (North America)
Notable Investments
Last updated: Jun 11, 2026